Thomas Joseph Tracy - Mar 7, 2025 Form SCHEDULE 13D Schedule Report for Transcode Therapeutics, Inc. (RNAZ)

Filing Manager: Tracy Thomas Joseph
Reporting Manager: Thomas Joseph Tracy
Security: Transcode Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: RNAZ
Shares outstanding: 700K shares
Disclosed Ownership: 35K shares
Ownership: 5%
Form type: SCHEDULE 13D
Date filed: 3/20/2025, 05:16 PM
Date of event: Mar 7, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Thomas Joseph Tracy	5%	35K	35K	0	/s/ Thomas Joseph Tracy	Thomas Joseph Tracy	0002062715